AMETEK, Inc. is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annual sales of approximately $9.0 billion.
AMETEK is a leading global provider of industrial technology solutions with approximately 22,500 colleagues across our global network of operating, sales, service, and support locations in 34 countries around the world. Our mission is to solve our customers' most complex challenges with differentiated technology solutions.
The AMETEK Growth Model is embedded within our culture and is made up of our four growth strategies – Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions. These growth strategies are complemented by a disciplined focus on cash generation, capital deployment, and talent development. Each element of our Growth Model reinforces the others, creating a powerful and scalable platform to drive long-term, sustainable growth.
AMETEK consists of two operating groups, both with highly differentiated technology and leading positions in niche markets:
• Electronic Instruments Group (EIG) – a leader in the design and manufacturing of advanced analytical, test and measurement instrumentation for aerospace, medical, power, energy, research and industrial markets.
• Electromechanical Group (EMG) – a leader in the design and manufacturing of highly engineered medical components and devices, automation solutions, thermal management systems, specialty metals and electrical interconnects.
Our global associates are unified by a singular drive: to take on our customers’ biggest challenges. To solve the critical problems that stand in the way of advancing health, safety and the environment.
Where others see something that can’t be done, we jump in fully committed to do it. We push the limits of science and technology. We redefine partnership through deeper, more meaningful collaboration. It’s how we’ve approached our calling since 1946. And why today you’ll find our filtration, separation and purification solutions at work in so many places.
From life-saving gene therapies to airplane engines.
Hydraulic systems to injectable medications.
Scotch. Smartphones. OLED screens. Paper.
Everyday Pall is there, helping protect critical operating assets, improve product quality, minimize emissions and waste, and safeguard health. No matter what, no matter where, we innovate and collaborate to deliver the one thing our customers need most:
The unsolvable, solved. More here: http://www.pall.com.
*******
Pall Corporation is proud to be part of Danaher, a global life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health.
As part of Danaher, Pall Corporation is connected to a uniquely broad ecosystem of expertise, technologies, and capabilities. Together, we partner closely with customers to solve their toughest challenges with greater speed and certainty.
Powered by the rigor of the Danaher Business System and a culture of continuous improvement, we make time a competitive advantage for our customers and help unlock the transformative potential of science and technology to improve billions of lives every day.
R&D Systems™ by Bio‑Techne, provides analytical instruments, reagents, and scientific support designed to perform in demanding research workflows. Our solutions are developed, validated, and supported with researchers’ core questions at the center, helping reduce variability, generate clearer results, and build confidence in data.
Our integrated offering spans highly cited proteins, antibodies, immunoassays, and small molecules from R&D Systems, Tocris, and Novus, alongside protein analysis instruments built on the foundation of ProteinSimple innovation. Together, these solutions support research from discovery through translational and clinical applications.
R&D Systems™ is a trademark of Bio-Techne Corporation.